Influenza and respiratory vaccines play a crucial role in safeguarding against various respiratory illnesses. The influenza vaccine, often recommended annually, helps protect against specific strains of the flu virus, reducing the severity of symptoms and the risk of complications. Respiratory vaccines, covering a broader spectrum, aim to prevent infections such as pneumonia, whooping cough, and certain types of meningitis. These vaccines bolster the body's immune response, fortifying defenses against respiratory pathogens. They are especially vital for vulnerable populations, including the elderly, young children, and individuals with underlying health conditions, minimizing the likelihood of severe respiratory infections. By receiving these vaccines, individuals not only protect themselves but also contribute to broader community immunity, reducing the spread of respiratory illnesses during peak seasons. Regular vaccination remains a cornerstone in public health efforts to mitigate the impact of respiratory diseases worldwide.
Title : Novel regulatory mechanisms of innate immunity and inflammation
Ping Xie, Rutgers University, United States
Title : Human challenge clinical trial of vaccines for infectious diseases – A necessary evil
Sudhakar Bangera, AILEEN Clinical Research Services, India
Title : Your vaccine attitude determines your altitude. What are the determinants of attitudes toward vaccination
Vincenzo Alfano, University of Napoli Parthenope, Italy
Title : Neutralizing antibodies response to SARS-COV-2 XBB1.5 mRNA vaccine in nephrology patients on dialysis against different viral variants
Agostino Riva, University of Milan, Italy
Title : Why Antimicrobial Resistance is a Global Threat and Its Impact On Everyone
Regina Au, BioMarketing Insight, United States
Title : The influence of physical factors on recombinant human serum albumin
Patrycja Dolibog, Medical University of Silesia in Katowice, Poland
Title : Current investments and future directions of biomedical advanced research and development authority’s CBRN vaccines portfolio
Lindsay Parish, BARDA, United States
Title : Development and characterization of a virus-like particle-based subunit vaccine candidate against Indian isolate of Porcine Circovirus 2d
Rajib Deb, ICAR-National Research Centre on Pig, India
Title : The Ethiopian vaccine supply chain and logistics system’s performance after the last mile delivery initiative: Phenomenological study
Samson Gebremedhin Gebreselassie, Project HOPE, Ethiopia
Title : Limits of vaccine quality control in India: Possible solutions
Bhoj R Singh, Indian Veterinary Research Institute, India